BROADVIEW HEIGHTS, Ohio -- In a letter dated Nov. 17, 2003, the Occupational Safety and Health Administration (OSHA) acknowledged that the use of devices such as the Disintegrator PRO would comply with the requirements of the bloodborne pathogens regulations in appropriate settings. The product is manufactured by Safeguard Medical Devices, Inc., d.b.a. Disintegrator Products.
In response to a May 30, 2003 letter from the firm, OSHA stated, "The requirements of the standards are performance based" and that "compliance was determined on a facility-by-facility basis." OSHA further clarified that "Where SESIPs are not effective, available, or appropriate the employer must look at other means to reduce exposure . which would include a NDD (needle destruction device)."
According to OSHA's letter, the employer is to determine the most effective means of preventing accidental needlesticks, with input from non-managerial employees, and document the consideration and selection of the engineering control in their ECP (exposure control plan). Once the employer determines that an engineering control is effective, they are not required to evaluate all available new controls every year, but to simply keep abreast of new technologies and document this in their ECP.
With the push of a button, the compact PRO unit is designed to create a small plasma arc that literally melts the steel needle tip, leaving a blunt, sealed and safe endpoint. During the process, the needle tip is heated to approximately 3,000 degrees Fahrenheit, practically ensuring the elimination of any pathogens.
The lightweight unit operates from either ac current or the built-in rechargeable battery, and is FDA approved for use with most common needles, lancets and pre-filled vials.
The unit serves as an effective, inexpensive solution to the challenging problem of reducing needlestick exposure in many professional settings.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.